1.Clinical Analysis of Patients with MGUS, Primary Light Chain Amyloidosis, Multiple Myeloma or Multiple Myeloma with Concurrent Amyloidosis.
Xue-Han MAO ; Shu-Hui DENG ; Wei-Wei SUI ; Ming-Wei FU ; Jia-Hui LIU ; Hui-Shou FAN ; De-Hui ZOU ; Yao-Zhong ZHAO ; Lu-Gui QIU ; Gang AN
Journal of Experimental Hematology 2021;29(3):812-818
OBJECTIVE:
To summarize and compare the clinical baseline characteristics of patients with monoclonal gammopathy of undetermined significance (MGUS), primary light chain amyloidosis (pAL), multiple myeloma (MM), or MM with concurrent amyloidosis, especially the differences in cytogenetic abnormalities.
METHODS:
The clinical data of 15 cases of MGUS, 34 cases of pAL, 842 cases of MM and 23 cases of MM with concurrent amyloidosis were analyzed and compared retrospectively.
RESULTS:
Cytogenetic statistics showed that the incidence of t (11; 14) in the four groups (MGUS vs pAL vs MM vs MM with concurrent amyloidosis) was 0%, 33.3%, 16.4%, and 15.8%, respectively (P=0.037); that of 13q deletion was 20.0%, 14.7%, 45.8% and 56.5%, respectively (P<0.001); gain of 1q21 was 50.0%, 12.5%, 47.4% and 40.9%, respectively (P=0.001). Proportion of pAL patients with 0, 1 and≥2 cytogenetic abnormalities (including 13q deletion, 17p deletion, 1q21 amplification and IgH translocation) accounted for 41.9%, 41.9% and 16.1%, respectively; while the proportion of the same category in MM was 17.6%, 27.3%, and 55.2% respectively; this ratio of MM with concurrent amyloidosis was more similar to MM. Subgroup analysis showed that genetic abnormalities (including 13q deletion, 17p deletion and 1q21 amplification) were comparable within t (11; 14) negative and positive groups. Compared with positive cases, t(11; 14) negative patients with MM or MGUS were more likely to have 13q deletions and multiple genetic abnormalities.
CONCLUSION
Clinical characteristics of pAL, especially cytogenetic abnormalities, are significantly different from MM with concurrent amyloidosis. It suggests that although the onset characteristics are similar, actually the two diseases belong to different disease subtypes which should be carefully predicted and identified.
Amyloidosis
;
Humans
;
In Situ Hybridization, Fluorescence
;
Monoclonal Gammopathy of Undetermined Significance/complications*
;
Multiple Myeloma
;
Retrospective Studies
2.A Case of Crystalline Keratopathy in Monoclonal Gammopathy of Undetermined Significance (MGUS).
Hyun KOO ; Doo Hwan OH ; Yeoun Sook CHUN ; Jae Chan KIM
Korean Journal of Ophthalmology 2011;25(3):202-205
A 62-year-old female visited our clinic with progressively decreased vision in both eyes beginning 12 years prior. Idiopathic corneal opacity in all layers of the cornea was found in both eyes. One year later, we performed penetrating keratoplasty on the undiagnosed right eye. During post-surgical follow-up, corneal edema and stromal opacity recurred, and penetrating keratoplasty was performed two more times. The patient's total serum protein level, which had previously been normal, was elevated prior to the final surgery. She was diagnosed with monoclonal gammopathy of undetermined significance. We made a final diagnosis of monoclonal gammopathy-associated crystalline keratopathy after corneal biopsy. Monoclonal gammopathy-associated crystalline keratopathy is difficult to diagnose and may lead to severe visual loss. A systemic work-up, including serologic tests like serum protein or cholesterol levels, is needed in patients with unexplainable corneal opacity.
Corneal Edema/etiology/*metabolism/physiopathology/surgery
;
Corneal Neovascularization/etiology/*metabolism/physiopathology/surgery
;
Corneal Opacity/etiology/*metabolism/physiopathology/surgery
;
Crystallins/*metabolism
;
Female
;
Humans
;
Keratoplasty, Penetrating
;
Microscopy, Electron
;
Middle Aged
;
Monoclonal Gammopathy of Undetermined Significance/*complications/pathology
;
Reoperation
;
Visual Acuity